These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


141 related items for PubMed ID: 920225

  • 21. Development of the Clozaril Patient Management System.
    Bastani B, Alphs LD, Meltzer HY.
    Psychopharmacology (Berl); 1989; 99 Suppl():S122-5. PubMed ID: 2813664
    [Abstract] [Full Text] [Related]

  • 22. [Remarks on clozapine].
    Steinbauer G, Diehl LW.
    Nervenarzt; 1980 Jun; 51(6):373-4. PubMed ID: 7453889
    [No Abstract] [Full Text] [Related]

  • 23. Notes from a state mental health directors' meeting on clozapine.
    Salzman C.
    Hosp Community Psychiatry; 1990 Aug; 41(8):838-9, 842. PubMed ID: 2401474
    [No Abstract] [Full Text] [Related]

  • 24. Hematological adverse events in clozapine-treated children and adolescents.
    Gerbino-Rosen G, Roofeh D, Tompkins DA, Feryo D, Nusser L, Kranzler H, Napolitano B, Frederickson A, Henderson I, Rhinewine J, Kumra S.
    J Am Acad Child Adolesc Psychiatry; 2005 Oct; 44(10):1024-31. PubMed ID: 16175107
    [Abstract] [Full Text] [Related]

  • 25. Does switching to another antipsychotic in patients with clozapine-associated granulocytopenia solve the problem? Case series of 18 patients.
    Coşar B, Taner ME, Eser HY, Altınöz AE, Tarhan R.
    J Clin Psychopharmacol; 2011 Apr; 31(2):169-73. PubMed ID: 21346615
    [Abstract] [Full Text] [Related]

  • 26. FDA's position on the clozaril patient management system.
    Peck CC.
    Hosp Community Psychiatry; 1990 Aug; 41(8):876-7. PubMed ID: 2401475
    [No Abstract] [Full Text] [Related]

  • 27. [Acute bone marrow and liver damage during treatment with clozapine].
    Brodowski L, Matusewicz W, Urbańska-Ryś H, Krykowski E.
    Pol Tyg Lek; 1984 May 21; 39(21):721-2. PubMed ID: 6483677
    [No Abstract] [Full Text] [Related]

  • 28. Agranulocytosis: incidence and risk factors.
    Alvir JM, Lieberman JA.
    J Clin Psychiatry; 1994 Sep 21; 55 Suppl B():137-8. PubMed ID: 7961558
    [Abstract] [Full Text] [Related]

  • 29. [The most common complications in neuroleptic therapy. A case report].
    Preradović M.
    Vojnosanit Pregl; 1981 Sep 21; 38(3):211-2. PubMed ID: 7281540
    [No Abstract] [Full Text] [Related]

  • 30. Clozapine for schizophrenia.
    Med Lett Drugs Ther; 1990 Jan 12; 32(809):3-4. PubMed ID: 2403629
    [No Abstract] [Full Text] [Related]

  • 31. HLA-associations in Leponex/Clozaril (clozapine)-induced granulocytopenia and agranulocytosis. Statistical viewpoints.
    Abt K, Gülich A, Krupp P, Reinberg W.
    Drug Saf; 1992 Jan 12; 7 Suppl 1():10-6. PubMed ID: 1503672
    [Abstract] [Full Text] [Related]

  • 32. Sudden late onset of clozapine-induced agranulocytosis.
    Patel NC, Dorson PG, Bettinger TL.
    Ann Pharmacother; 2002 Jun 12; 36(6):1012-5. PubMed ID: 12022904
    [Abstract] [Full Text] [Related]

  • 33. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland.
    Atkin K, Kendall F, Gould D, Freeman H, Liberman J, O'Sullivan D.
    Br J Psychiatry; 1996 Oct 12; 169(4):483-8. PubMed ID: 8894200
    [Abstract] [Full Text] [Related]

  • 34. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
    Hägg S, Rosenius S, Spigset O.
    Int Clin Psychopharmacol; 2003 May 12; 18(3):173-4. PubMed ID: 12702898
    [Abstract] [Full Text] [Related]

  • 35. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States.
    Alvir JM, Lieberman JA, Safferman AZ, Schwimmer JL, Schaaf JA.
    N Engl J Med; 1993 Jul 15; 329(3):162-7. PubMed ID: 8515788
    [Abstract] [Full Text] [Related]

  • 36. Clozapine-associated agranulocytosis: risk and aetiology.
    Krupp P, Barnes P.
    Br J Psychiatry Suppl; 1992 May 15; (17):38-40. PubMed ID: 1418887
    [Abstract] [Full Text] [Related]

  • 37. Clozapine--a new and different neuroleptic.
    Haller E, Binder RL.
    West J Med; 1990 Jul 15; 153(1):62-4. PubMed ID: 2389576
    [Abstract] [Full Text] [Related]

  • 38. Late-onset clozapine-induced agranulocytosis in a patient with comorbid multiple sclerosis.
    Raveendranathan D, Sharma E, Venkatasubramanian G, Rao MG, Varambally S, Gangadhar BN.
    Gen Hosp Psychiatry; 2013 Jul 15; 35(5):574.e5-6. PubMed ID: 22902258
    [Abstract] [Full Text] [Related]

  • 39. Late-onset agranulocytosis in a patient treated with clozapine and lamotrigine.
    Tourian L, Margolese HC.
    J Clin Psychopharmacol; 2011 Oct 15; 31(5):665-7. PubMed ID: 21881454
    [No Abstract] [Full Text] [Related]

  • 40. Role of clozapine in the occurrence of chromosomal abnormalities in human bone-marrow cells in vivo and in cultured lymphocytes in vitro.
    Knuutila S, Helminen E, Knuutila L, Leisti S, Siimes M, Tammisto P, Westermarck T.
    Hum Genet; 1977 Aug 31; 38(1):77-89. PubMed ID: 903157
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.